Remab Pharmaceuticals Private Limited, a active private limited company, was established on 21 February 2013 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U24100WB2013PTC190819. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Atanu Das (Director), Manik Lal Das (Director). It holds ₹2.17 M open charges and no settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at 3/2/F/1, Prafulla Chaki Road, Baranagar,, Kolkata, West Bengal, 700036.
U24100WB2013PTC190819
190819
21 February 2013
₹0.10 M
₹0.10 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Remab Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Atanu Das | Director | 21 Feb 2013 | Current |
| Manik Lal Das | Director | 21 Feb 2013 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Remab Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 3.35% decrease. The company also saw a substantial improvement in profitability, with a 35.75% increase in profit. The company's net worth Soared by an impressive increase of 14.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Remab Pharmaceuticals had a promoter holding of 70.00% and a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,170,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 May 2018 | Indian Bank | ₹2.17 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Remab Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Remab Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Remab Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Indian Bank of Rs. 2.17 M registered on 21 May 2018 with Charge ID 100221609 was modified on 12 Jul 2023. was recorded as a recent event.
Remab Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was recorded as a recent event.
Remab Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Kolkata. was recorded as a recent event.
The activity A charge with Indian Bank amounted to Rs. 2.17 M with Charge ID 100221609 was registered on 21 May 2018. was completed.
Progress on Atanu Das was appointed as a Director was appointed as a Director on 21 Feb 2013 & has been associated with this company since 12 years 9 months . was documented.
The activity Manik Lal Das was appointed as a Director was appointed as a Director on 21 Feb 2013 & has been associated with this company since 12 years 9 months . was completed.
The CIN of Remab Pharmaceuticals Private Limited is U24100WB2013PTC190819.
Remab Pharmaceuticals Private Limited is headquartered at 3/2/F/1, Prafulla Chaki Road, Baranagar,, Kolkata, West Bengal, 700036.
Remab Pharmaceuticals Private Limited was incorporated on 21 February 2013.
The current directors of Remab Pharmaceuticals Private Limited are
The primary industry of Remab Pharmaceuticals Private Limited is Hospital And Medical Care.
Remab Pharmaceuticals Private Limited is unlisted.
The authorized capital of Remab Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Remab Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX